Canada markets closed

ADMA Biologics, Inc. (ADMA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.67+0.15 (+2.30%)
At close: 04:00PM EDT
6.66 -0.01 (-0.15%)
After hours: 06:09PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.51B
Enterprise Value 1.60B
Trailing P/E N/A
Forward P/E 22.47
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.66
Price/Book (mrq)11.18
Enterprise Value/Revenue 6.20
Enterprise Value/EBITDA 312.74

Trading Information

Stock Price History

Beta (5Y Monthly) 0.43
52-Week Change 387.36%
S&P500 52-Week Change 323.10%
52 Week High 36.76
52 Week Low 33.06
50-Day Moving Average 36.09
200-Day Moving Average 34.58

Share Statistics

Avg Vol (3 month) 32.5M
Avg Vol (10 day) 32.12M
Shares Outstanding 5231.77M
Implied Shares Outstanding 6231.77M
Float 8223.68M
% Held by Insiders 12.84%
% Held by Institutions 175.42%
Shares Short (Apr 15, 2024) 48.11M
Short Ratio (Apr 15, 2024) 43.32
Short % of Float (Apr 15, 2024) 43.60%
Short % of Shares Outstanding (Apr 15, 2024) 43.50%
Shares Short (prior month Mar 15, 2024) 47.99M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -10.94%
Operating Margin (ttm)19.26%

Management Effectiveness

Return on Assets (ttm)4.51%
Return on Equity (ttm)-19.67%

Income Statement

Revenue (ttm)258.22M
Revenue Per Share (ttm)1.15
Quarterly Revenue Growth (yoy)47.90%
Gross Profit (ttm)N/A
EBITDA 32.76M
Net Income Avi to Common (ttm)-28.24M
Diluted EPS (ttm)-0.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)51.35M
Total Cash Per Share (mrq)0.22
Total Debt (mrq)141.42M
Total Debt/Equity (mrq)104.59%
Current Ratio (mrq)5.16
Book Value Per Share (mrq)0.60

Cash Flow Statement

Operating Cash Flow (ttm)8.8M
Levered Free Cash Flow (ttm)378.12k